Cargando…
Biomarker and genomic analyses reveal molecular signatures of non-cardioembolic ischemic stroke
Acute ischemic stroke (AIS) is a major cause of disability and mortality worldwide. Non-cardioembolic ischemic stroke (NCIS), which constitutes the majority of AIS cases, is highly heterogeneous, thus requiring precision medicine treatments. This study aimed to investigate the molecular mechanisms u...
Autores principales: | Ding, Lingling, Liu, Yu, Meng, Xia, Jiang, Yong, Lin, Jinxi, Cheng, Si, Xu, Zhe, Zhao, Xingquan, Li, Hao, Wang, Yongjun, Li, Zixiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227023/ https://www.ncbi.nlm.nih.gov/pubmed/37248226 http://dx.doi.org/10.1038/s41392-023-01465-w |
Ejemplares similares
-
Data-driven clustering approach to identify novel phenotypes using multiple biomarkers in acute ischaemic stroke: A retrospective, multicentre cohort study
por: Ding, Lingling, et al.
Publicado: (2022) -
Blood Biomarkers in Cardioembolic Stroke
por: García-Berrocoso, Teresa, et al.
Publicado: (2010) -
Atrial fibrillation is not uncommon among patients with ischemic stroke and transient ischemic stroke in China
por: Yang, Xiaomeng, et al.
Publicado: (2017) -
Bayés syndrome and acute cardioembolic ischemic stroke
por: Arboix, Adrià, et al.
Publicado: (2017) -
Residual Risk and Its Risk Factors for Ischemic Stroke with Adherence to Guideline-Based Secondary Stroke Prevention
por: Pan, Yuesong, et al.
Publicado: (2021)